JNGLX
Price
$67.24
Change
+$0.25 (+0.37%)
Updated
Jul 25 closing price
Net Assets
4.4B
RYHAX
Price
$104.61
Change
+$0.45 (+0.43%)
Updated
Jul 25 closing price
Net Assets
18.37M
Interact to see
Advertisement

JNGLX vs RYHAX

Header iconJNGLX vs RYHAX Comparison
Open Charts JNGLX vs RYHAXBanner chart's image
Janus Henderson Global Life Sciences D
Price$67.24
Change+$0.25 (+0.37%)
VolumeN/A
Net Assets4.4B
Rydex Health Care H
Price$104.61
Change+$0.45 (+0.43%)
VolumeN/A
Net Assets18.37M
JNGLX vs RYHAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JNGLX vs. RYHAX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Buy and RYHAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.4B vs. RYHAX (18.4M). JNGLX pays higher dividends than RYHAX: JNGLX (0.36) vs RYHAX (0.00). JNGLX was incepted earlier than RYHAX: JNGLX (27 years) vs RYHAX (27 years). RYHAX (1.68) is less costly to investors than JNGLX (0.80). RYHAX is a more actively managed with annual turnover of: 236.00 vs. JNGLX (35.00). JNGLX (2500) and RYHAX (2500) have matching initial minimum investment requirements. RYHAX annual gain was more profitable for investors over the last year : -5.78 vs. JNGLX (-14.43). RYHAX return over 5 years is better than : 5.95 vs. JNGLX (4.98).
JNGLXRYHAXJNGLX / RYHAX
Total Expense Ratio0.801.6548%
Annual Report Gross Expense Ratio0.801.6848%
Fund Existence27 years27 years-
Gain YTD-1.3260.755-176%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets4.4B18.4M23,924%
Annual Yield % from dividends0.360.00-
Returns for 1 year-14.43-5.78250%
Returns for 3 years8.836.05146%
Returns for 5 years4.985.9584%
Returns for 10 years6.800.461,468%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GHTMX15.40N/A
N/A
Goldman Sachs International T/M Eq Instl
MSGFX33.43N/A
N/A
Morgan Stanley Inst Global Franchise C
JGTUX43.90N/A
N/A
JPMorgan Growth Advantage R4
BAFMX18.34N/A
N/A
Brown Advisory Mid-Cap Growth Instl
TRMNX22.61N/A
N/A
T. Rowe Price Mid-Cap Index